Zhao Ashley G, Shah Kiran, Cromer Brett, Sumer Huseyin
Department of Chemistry and Biotechnology, Faculty of Science, Engineering and Technology, Swinburne University of Technology, John St., Hawthorn VIC 3122, Australia.
Magellan Stem Cells P/L, 116-118 Thames St., Box Hill VIC 3129, Australia.
Stem Cells Int. 2020 Aug 24;2020:8825771. doi: 10.1155/2020/8825771. eCollection 2020.
Extracellular vesicles (EVs) are cell-derived membrane-bound nanoparticles, which act as shuttles, delivering a range of biomolecules to diverse target cells. They play an important role in maintenance of biophysiological homeostasis and cellular, physiological, and pathological processes. EVs have significant diagnostic and therapeutic potentials and have been studied both and in many fields. Mesenchymal stem cells (MSCs) are multipotent cells with many therapeutic applications and have also gained much attention as prolific producers of EVs. MSC-derived EVs are being explored as a therapeutic alternative to MSCs since they may have similar therapeutic effects but are cell-free. They have applications in regenerative medicine and tissue engineering and, most importantly, confer several advantages over cells such as lower immunogenicity, capacity to cross biological barriers, and less safety concerns. In this review, we introduce the biogenesis of EVs, including exosomes and microvesicles. We then turn more specifically to investigations of MSC-derived EVs. We highlight the great therapeutic potential of MSC-derived EVs and applications in regenerative medicine and tissue engineering.
细胞外囊泡(EVs)是细胞衍生的膜结合纳米颗粒,它们充当穿梭载体,将一系列生物分子传递给不同的靶细胞。它们在维持生物生理稳态以及细胞、生理和病理过程中发挥着重要作用。EVs具有显著的诊断和治疗潜力,并且在许多领域都得到了研究。间充质干细胞(MSCs)是具有多种治疗应用的多能细胞,作为丰富的EVs生产者也备受关注。源自MSC的EVs正被探索作为MSCs的一种治疗替代物,因为它们可能具有相似的治疗效果,但却是无细胞的。它们在再生医学和组织工程中有应用,最重要的是,与细胞相比具有几个优势,如较低的免疫原性、穿越生物屏障的能力以及较少的安全问题。在这篇综述中,我们介绍了EVs的生物发生,包括外泌体和微囊泡。然后我们更具体地转向对源自MSC的EVs的研究。我们强调了源自MSC的EVs在再生医学和组织工程中的巨大治疗潜力及应用。